Pancreatic Cancer Research

ResearcherTianjin Medical University Cancer Institute and HospitalActive in the last 2 years

Ji-Hui Hao

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5100516855. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. TGF-β-Targeting Platinum(IV) Prodrugs Remodel Tumor Microenvironment of Pancreatic Cancer via Antifibrotic and Immunomodulatory Effects. Last author DOI 10.1021/acs.jmedchem.6c01687↗
  2. Clinical and Prognostic Significance of Coagulation Assays in Pancreatic Cancer Patients With Absence of Venous Thromboembolism. Last author DOI 10.1097/01.coc.0000436088.69084.22↗
  3. Improvement in treatment and outcome of pancreatic ductal adenocarcinoma in north China. First author DOI 10.1007/s11605-011-1493-y↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhe Li · 1 shared paper, 2026 · strength 0.26
  2. Xiaomeng Liu · 1 shared paper, 2026 · strength 0.26
  3. Peng Jin · 1 shared paper, 2015 · strength 0.05
  4. Wei Sun · 1 shared paper, 2015 · strength 0.05
  5. Lin Luo · 1 shared paper, 2015 · strength 0.05
  6. Xi-Shan Hao · 1 shared paper, 2011 · strength 0.03
  7. Weidong Ma · 1 shared paper, 2011 · strength 0.03
  8. Yong Chen · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.